c-erbB2 receptor and P53 protein expression in canine mammary gland carcinoma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Comparative Clinical Pathology

• Publication date

  2012-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00580-011-1339-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Immuno-histochemical staining expression of Ki67 protein in canine mammary gland carcinoma

  2011cited by this paper
• Grading in canine mammary gland carcinoma.

  2009cited by this paper
• Tumors of the Mammary Gland

  2008cited by this paper
• Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

  2008cited by this paper
• Spontaneous Mammary Intraepithelial Lesions in Dogs—A Model of Breast Cancer

  2007cited by this paper
• 25 years of p53 research

  2005cited by this paper
• Overexpression of HER-2 in Feline Invasive Mammary Carcinomas: An Immunohistochemical Survey and Evaluation of Its Prognostic Potential

  2005cited by this paper
• Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer.

  2005cited by this paper
• Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.

  2004cited by this paper
• c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors.

  2004influential reference
• Overexpression of the erbB-2 Proto-oncogene in Canine Osteosarcoma Cell Lines and Tumors

  2004cited by this paper
• Clinical and Pathologic Relevance of p53 Index in Canine Osseous Tumors

  2003cited by this paper
• Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

  2003cited by this paper
• Structure of HER receptors and intracellular localisation of downstream effector elements gives insight into mechanism of tumour growth promotion

  2003cited by this paper
• Oncogene HER-2 in Canine Mammary Gland Carcinomas

  2003influential reference
• Immunohistochemical and Clinical Evaluation of p53 in Canine Cutaneous Mast Cell Tumors

  2000cited by this paper
• Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors.

  1999influential reference
• Histological classification of mammary tumors of the dog and the cat

  1999cited by this paper
• Immunohistochemical Detection of p53 Tumor Suppressor Gene Protein in Canine Epithelial Colorectal Tumors

  1997cited by this paper
• Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.

  1996cited by this paper
• Tumors in domestic animals

  1961cited by this paper

• Polymorphism of P53-Ets/AP1 transactivation region of MDM2 oncogene and its immunohistochemical analysis in canine tumours.

  2016cites this paper
• Retrospective study and immunohistochemical analysis of canine mammary sarcomas

  2013cites this paper